Literature DB >> 9039978

Role of increased production of monocytes TNF-alpha, IL-1beta and IL-6 in psoriasis: relation to focal infection, disease activity and responses to treatments.

H Mizutani1, Y Ohmoto, T Mizutani, M Murata, M Shimizu.   

Abstract

To evaluate the immunological function of peripheral blood monocytes (PBMC) in psoriasis, we measured spontaneous production of the inflammatory cytokines, TNF-alpha, IL-1beta and IL-6 from the PBMC of psoriasis patients, by enzyme linked immunosorbent assay (ELISA). The production of all three inflammatory cytokines by psoriatic PBMC was significantly higher than that by normal control PBMC. PBMC sampled from active psoriasis produced three cytokines significantly higher than samples from inactive psoriasis. In addition, IL-1beta and TNF-alpha production showed a positive relation to clinical severity, but IL-6 did not. TNF-alpha production increased much more than did the others. Therefore, the TNF-alpha to IL-1beta ratio was significantly higher, even in inactive psoriasis, than that of the normal control. In relation to focal infection, psoriatic PBMC sampled 3 h after a tonsillar provocation test increased cytokine production, compared with the level before provocation. The cases which responded to tonsillectomy or systemic methotrexate therapy, but not the non-responding cases, showed a significant decrease in PBMC cytokine productivity. These results strongly suggest that inflammatory cytokines, especially TNF-alpha, from monocytes are involved in the pathogenesis of psoriasis, and activated monocytes may work as an effective mediator of focal infection in skin lesions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039978     DOI: 10.1016/s0923-1811(96)00562-2

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  23 in total

Review 1.  Safety of etanercept in psoriasis: a critical review.

Authors:  Jose L Sánchez Carazo; Laura Mahiques Santos; Vicente Oliver Martinez
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  IL-17 induces inflammation-associated gene products in blood monocytes, and treatment with ixekizumab reduces their expression in psoriasis patient blood.

Authors:  Claire Q F Wang; Mayte Suárez-Fariñas; Kristine E Nograles; Claudia A Mimoso; David Shrom; Ernst R Dow; Michael P Heffernan; Robert W Hoffman; James G Krueger
Journal:  J Invest Dermatol       Date:  2014-07-07       Impact factor: 8.551

3.  Expression of tumor necrosis factor alpha-induced protein 3 mRNA in peripheral blood mononuclear cells negatively correlates with disease severity in psoriasis vulgaris.

Authors:  Xuebing Jiang; Hongqing Tian; Yuchen Fan; Jie Chen; Yonghong Song; Shurong Wang; Faliang Zhu; Chun Guo; Lining Zhang; Yongyu Shi
Journal:  Clin Vaccine Immunol       Date:  2012-10-10

4.  Hypothalamic involvement in chronic migraine.

Authors:  M F Peres; M Sanchez del Rio; M L Seabra; S Tufik; J Abucham; J Cipolla-Neto; S D Silberstein; E Zukerman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

Review 5.  The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature.

Authors:  Marina Talamonti; Simone D'Adamio; Luca Bianchi; Marco Galluzzo
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

6.  Decreased expression levels of L-selectin on subsets of leucocytes and increased serum L-selectin in severe psoriasis.

Authors:  M Inaoki; S Sato; Y Shimada; S Kawara; D A Steeber; T F Tedder; K Takehara
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

Review 7.  A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses.

Authors:  Kamran Ghoreschi; Ulrich Mrowietz; Martin Röcken
Journal:  J Mol Med (Berl)       Date:  2003-07-18       Impact factor: 4.599

8.  Tumor necrosis factor-α promotes and exacerbates calcification in heart valve myofibroblast populations.

Authors:  Andrea Gonzalez Rodriguez; Megan E Schroeder; Joseph C Grim; Cierra J Walker; Kelly F Speckl; Robert M Weiss; Kristi S Anseth
Journal:  FASEB J       Date:  2021-03       Impact factor: 5.834

9.  Pathological role of interleukin-6 in psoriatic arthritis.

Authors:  Atsushi Ogata; Atsushi Kumanogoh; Toshio Tanaka
Journal:  Arthritis       Date:  2012-10-11

10.  Adalimumab (tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina.

Authors:  I Fernandez-Bueno; M T Garcia-Gutierrez; G K Srivastava; M J Gayoso; J M Gonzalo-Orden; J C Pastor
Journal:  Mol Vis       Date:  2013-04-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.